Medicine Overview of Miconex 2% Cream
Topical/Cutaneous
Adult:
Tinea cruris, corporis & cutaneous canidiasis: Apply to affected area BID for 2 weeks
Tinea versicolor: Apply once daily to affected area for 2 weeks
Tinea pedis: Apply BID to affected area for 4 weeks
Show less
Tinea
<2 years: Safety and efficacy not established
>2 years: Apply BID for up to 1 month
Show less
For external use only. Avoid introduction into the eyes.
Lactation: not known whether distributed into milk; use caution
Show less
Irritation,BurningmMaceration,Allergic contact dermatitis
Irritation, burning, maceration, allergic contact dermatitis (all rare)
Show less
May increase anticoagulant effect of warfarin. May increase or prolong the effect of the following drugs: Oral hypoglycaemics (e.g. sulfonylureas), phenytoin, HIV protease inhibitors (e.g. saquinavir), antineoplastic agents (e.g. vinca alkaloids, busulfan, docetaxel), Ca channel blockers (e.g. dihydropyridines, verapamil), immunosuppressive agents (e.g. ciclosporin, tacrolimus, sirolimus), carbamazepine, cilostazol, buspirone, disopyramide, alfentanil, sildenafil, alprazolam, brotizolam, midazolam IV, rifabutin, methylprednisolone, trimetrexate, ebastine and reboxetine.
Potentially Fatal: Increased risk of cardiac arrhythmia w/ astemizole, cisapride, dofetilide, halofantrine, mizolastine, pimozide, quinidine, sertindole, terfenadine. May increase exposure to ergot alkaloids leading to ergotism. May increase the risk of rhabdomyolysis w/ HMG-CoA reductase inhibitors (e.g. simvastatin and lovastatin). May increase the effect of triazolam and oral midazolam.
Show less
Reviews
Clear filtersThere are no reviews yet.